Clinical Trial Update: Effect of Nicotine on Brain Reward Pathways [Phase 1]

View source ↗

Summary

Phase 1 trial from McLean Hospital studied the impact of nicotine on brain reward pathways in individuals with major depressive disorder. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: Mclean Hospital | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED